Upregulated microRNA-301a in osteosarcoma promotes tumor progression by targeting CDC14A

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs (miRs) are key regulators of gene expression implicated in various cancers.
• miR-301a is recognized for its oncogenic role in several malignancies.
• Its specific involvement in osteosarcoma (OS) pathogenesis requires elucidation.

Purpose of the Study:

• To investigate the role of miR-301a in osteosarcoma (OS) development and progression.
• To analyze miR-301a expression levels in OS tissues.
• To determine the functional impact of miR-301a on OS cell behavior.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) for miR-301a expression analysis.
• Transfection of miR-301a mimics into OS cell lines (U-2 OS, MG-63) to upregulate its expression.
• Assessment of cell proliferation, migration, apoptosis, and cell cycle distribution.
• Target gene prediction (TargetScan) and validation (Western blotting, qRT-PCR).

Main Results:

• miR-301a expression was significantly elevated in OS tissues compared to adjacent non-tumor tissues.
• Upregulated miR-301a enhanced OS cell proliferation and migration while reducing apoptosis.
• miR-301a induced an increase in the G2 phase of the cell cycle.
• CDC14A was identified as a target gene upregulated by miR-301a.

Conclusions:

• Overexpression of miR-301a promotes osteosarcoma cell proliferation and migration, potentially by upregulating CDC14A.
• miR-301a demonstrates oncogenic activity in osteosarcoma.
• miR-301a holds potential as a biomarker for osteosarcoma diagnosis and a therapeutic target.